JP2017514501A5 - - Google Patents

Download PDF

Info

Publication number
JP2017514501A5
JP2017514501A5 JP2016566656A JP2016566656A JP2017514501A5 JP 2017514501 A5 JP2017514501 A5 JP 2017514501A5 JP 2016566656 A JP2016566656 A JP 2016566656A JP 2016566656 A JP2016566656 A JP 2016566656A JP 2017514501 A5 JP2017514501 A5 JP 2017514501A5
Authority
JP
Japan
Prior art keywords
rodent
gene
exon
human
modified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016566656A
Other languages
English (en)
Japanese (ja)
Other versions
JP6640740B2 (ja
JP2017514501A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/029638 external-priority patent/WO2015171861A1/en
Publication of JP2017514501A publication Critical patent/JP2017514501A/ja
Publication of JP2017514501A5 publication Critical patent/JP2017514501A5/ja
Application granted granted Critical
Publication of JP6640740B2 publication Critical patent/JP6640740B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016566656A 2014-05-07 2015-05-07 ヒト化ＩＬ−４およびＩＬ−４Ｒα動物 Active JP6640740B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461989757P 2014-05-07 2014-05-07
US61/989,757 2014-05-07
PCT/US2015/029638 WO2015171861A1 (en) 2014-05-07 2015-05-07 Humanized il-4 and il-4r alpha animals

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019235722A Division JP6838131B2 (ja) 2014-05-07 2019-12-26 ヒト化ＩＬ−４およびＩＬ−４Ｒα動物

Publications (3)

Publication Number Publication Date
JP2017514501A JP2017514501A (ja) 2017-06-08
JP2017514501A5 true JP2017514501A5 (enExample) 2018-05-24
JP6640740B2 JP6640740B2 (ja) 2020-02-05

Family

ID=53284509

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2016566656A Active JP6640740B2 (ja) 2014-05-07 2015-05-07 ヒト化ＩＬ−４およびＩＬ−４Ｒα動物
JP2019235722A Active JP6838131B2 (ja) 2014-05-07 2019-12-26 ヒト化ＩＬ−４およびＩＬ−４Ｒα動物
JP2021019538A Active JP7145250B2 (ja) 2014-05-07 2021-02-10 ヒト化ＩＬ－４およびＩＬ－４Ｒα動物
JP2022147925A Pending JP2022171841A (ja) 2014-05-07 2022-09-16 ヒト化ＩＬ－４およびＩＬ－４Ｒα動物
JP2024150803A Active JP7755699B2 (ja) 2014-05-07 2024-09-02 ヒト化ＩＬ－４およびＩＬ－４Ｒα動物

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2019235722A Active JP6838131B2 (ja) 2014-05-07 2019-12-26 ヒト化ＩＬ−４およびＩＬ−４Ｒα動物
JP2021019538A Active JP7145250B2 (ja) 2014-05-07 2021-02-10 ヒト化ＩＬ－４およびＩＬ－４Ｒα動物
JP2022147925A Pending JP2022171841A (ja) 2014-05-07 2022-09-16 ヒト化ＩＬ－４およびＩＬ－４Ｒα動物
JP2024150803A Active JP7755699B2 (ja) 2014-05-07 2024-09-02 ヒト化ＩＬ－４およびＩＬ－４Ｒα動物

Country Status (26)

Country Link
US (7) US9565841B2 (enExample)
EP (3) EP3027015B1 (enExample)
JP (5) JP6640740B2 (enExample)
KR (2) KR102517112B1 (enExample)
CN (2) CN106470545B (enExample)
AU (3) AU2015255977B2 (enExample)
BR (1) BR112016025745A2 (enExample)
CA (2) CA3207834C (enExample)
CY (2) CY1119773T1 (enExample)
DK (2) DK3281521T3 (enExample)
ES (2) ES2656529T3 (enExample)
HR (2) HRP20180242T1 (enExample)
HU (2) HUE038028T2 (enExample)
IL (3) IL304841B2 (enExample)
LT (2) LT3281521T (enExample)
MX (1) MX370672B (enExample)
NO (1) NO2785538T3 (enExample)
PH (1) PH12016502058A1 (enExample)
PL (2) PL3027015T3 (enExample)
PT (2) PT3281521T (enExample)
RS (2) RS62345B1 (enExample)
RU (1) RU2703139C2 (enExample)
SG (2) SG10201912354PA (enExample)
SI (2) SI3027015T1 (enExample)
SM (2) SMT202100560T1 (enExample)
WO (1) WO2015171861A1 (enExample)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO2785538T3 (enExample) 2014-05-07 2018-08-04
IL287519B2 (en) 2014-06-19 2024-01-01 Regeneron Pharma Non-human animals having a humanized programmed cell death 1 gene
US10626493B2 (en) * 2014-09-17 2020-04-21 Oerlikon Surface Solutions Ag, Pfäffikon Method for producing a double-layer coated cutting tool with improved wear resistance
RU2726446C2 (ru) 2014-11-24 2020-07-14 Регенерон Фармасьютикалз, Инк. Не относящиеся к человеку животные, экспрессирующие гуманизированный комплекс cd3
HUE064960T2 (hu) 2014-12-05 2024-04-28 Regeneron Pharma Differenciációs 47 gén humanizált klasztert tartalmazó nem-humán állatok
CN113412818B (zh) 2014-12-09 2022-11-04 瑞泽恩制药公司 具有人源化分化簇274基因的非人动物
WO2017087780A1 (en) 2015-11-20 2017-05-26 Regeneron Pharmaceuticals, Inc. Non-human animals having a humanized lymphocyte-activation gene 3
SG11201806176PA (en) 2016-02-04 2018-08-30 Regeneron Pharma Non-human animals having an engineered angptl8 gene
DK3422845T3 (da) 2016-02-29 2021-08-30 Regeneron Pharma Gnavere med et humaniseret tmprss-gen
TWI784988B (zh) * 2016-12-01 2022-12-01 美商再生元醫藥公司 治療發炎症狀的方法
MX2019012171A (es) 2017-04-13 2019-11-25 Regeneron Pharma Tratamiento e inhibicion de enfermedades pulmonares inflamatorias en pacientes que tienen alelos de riesgo en los genes que codifican la il33 e il1rl1.
CA3066918A1 (en) 2017-06-12 2018-12-20 Bluefin Biomedicine, Inc. Anti-il1rap antibodies and antibody drug conjugates
US20190098879A1 (en) 2017-09-29 2019-04-04 Regeneron Pharmaceuticals, Inc. Non-Human Animals Comprising A Humanized TTR Locus And Methods Of Use
JP7361031B2 (ja) 2017-11-30 2023-10-13 リジェネロン・ファーマシューティカルズ・インコーポレイテッド ヒト化ｔｒｋｂ遺伝子座を含む非ヒト動物
IL314733A (en) 2018-03-26 2024-10-01 Regeneron Pharma Humanized rodents for testing therapeutic agents
IL307286B2 (en) 2018-04-11 2026-03-01 Regeneron Pharma Methods and reagents for IL-33 quantification
JP7048051B2 (ja) 2018-07-11 2022-04-05 正徳 染井 痒みを軽減するアトピー性皮膚炎治療剤
HRP20240999T1 (hr) 2018-07-16 2024-10-25 Regeneron Pharmaceuticals, Inc. Glodavački modeli bolesti ditra i njihova upotreba
CN111057721B (zh) * 2018-10-12 2021-03-16 百奥赛图(北京)医药科技股份有限公司 人源化IL-4和/或IL-4Rα改造动物模型的制备方法及应用
CN114107385A (zh) * 2019-01-17 2022-03-01 百奥赛图(北京)医药科技股份有限公司 人源化转基因动物
KR102661779B1 (ko) 2019-04-04 2024-04-30 리제너론 파마슈티칼스 인코포레이티드 인간화 응고 인자 12 좌위를 포함하는 비-인간 동물
US11891618B2 (en) 2019-06-04 2024-02-06 Regeneron Pharmaceuticals, Inc. Mouse comprising a humanized TTR locus with a beta-slip mutation and methods of use
MX2021015122A (es) 2019-06-07 2022-04-06 Regeneron Pharma Animales no humanos que comprenden un locus de albumina humanizado.
US20220272953A1 (en) * 2019-07-29 2022-09-01 Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Genetically modified non-human animal with human or chimeric il33
WO2021027737A1 (en) * 2019-08-09 2021-02-18 Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Genetically modified non-human animal with human or chimeric il2ra
CN112779285B (zh) * 2019-11-11 2023-01-06 百奥赛图(北京)医药科技股份有限公司 人源化il-10和il-10ra基因改造动物的构建方法和应用
CN114786479B (zh) * 2019-12-25 2023-12-15 江苏集萃药康生物科技股份有限公司 一种il-15人源化小鼠模型及其用途
WO2021154791A1 (en) * 2020-01-28 2021-08-05 Regeneron Pharmaceuticals, Inc. Non-human animals comprising a humanized pnpla3 locus and methods of use
CN111149767B (zh) * 2020-02-24 2021-07-20 中南大学湘雅二医院 一种人源化皮肤型红斑狼疮小鼠模型的构建方法和应用
CN113527485B (zh) * 2020-04-17 2024-11-15 湖南麦济生物技术股份有限公司 抗人白细胞介素-4受体α抗体及其制备方法和应用
CN111808882B (zh) * 2020-09-01 2020-12-29 北京百奥赛图基因生物技术有限公司 Il7r基因人源化改造的动物模型的构建方法及其应用
CN111793646B (zh) * 2020-09-08 2021-01-15 北京百奥赛图基因生物技术有限公司 Il1r1基因人源化改造的非人动物的构建方法及其应用
CN111926039B (zh) * 2020-09-23 2021-03-16 百奥赛图(北京)医药科技股份有限公司 Il-13基因人源化的非人动物的构建方法和应用
JP2024500153A (ja) * 2020-12-21 2024-01-04 リジェネロン・ファーマシューティカルズ・インコーポレイテッド ヒト化ｔｓｌｐ遺伝子、ヒト化ｔｓｌｐ受容体遺伝子、及び／又はヒト化ｉｌ７ｒａ遺伝子を有する非ヒト動物
WO2022247936A1 (en) * 2021-05-28 2022-12-01 Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Genetically modified non-human animal with human or chimeric cd36
CN120035675A (zh) * 2022-09-28 2025-05-23 百奥赛图(北京)医药科技股份有限公司 一种il5和/或il5ra基因人源化修饰的非人动物
IL322030A (en) * 2023-01-11 2025-09-01 Regeneron Pharma Methods and systems for automated regulatory compliance testing
WO2025175099A1 (en) 2024-02-16 2025-08-21 Regeneron Pharmaceuticals, Inc. A rodent copd model

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU643427B2 (en) * 1988-10-31 1993-11-18 Immunex Corporation Interleukin-4 receptors
US6596541B2 (en) * 2000-10-31 2003-07-22 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
ES2463476T3 (es) 2004-10-19 2014-05-28 Regeneron Pharmaceuticals, Inc. Método para generar un ratón homocigótico para una modificación genética
JP2007252370A (ja) * 2006-02-22 2007-10-04 Institute Of Physical & Chemical Research Ｉｌ−４初期発現系トランスジェニック非ヒト動物およびその利用
US7608693B2 (en) * 2006-10-02 2009-10-27 Regeneron Pharmaceuticals, Inc. High affinity human antibodies to human IL-4 receptor
US20110016543A1 (en) * 2008-12-04 2011-01-20 Sigma-Aldrich Co. Genomic editing of genes involved in inflammation
CN102725400A (zh) * 2009-06-29 2012-10-10 麻省理工学院 制造人源化的非人类哺乳动物的方法
EP2456877A4 (en) * 2009-07-24 2012-05-30 Sigma Aldrich Co Llc METHOD OF GENOMIC PROCESSING
RU2425880C2 (ru) * 2009-07-30 2011-08-10 Учреждение Российской академии наук Институт общей генетики им. Н.И. Вавилова РАН Способ получения трансгенных мышей
EP4502152A3 (en) 2009-10-06 2025-04-30 Regeneron Pharmaceuticals, Inc. Genetically modified mice and engraftment
SG10202008003VA (en) * 2011-02-15 2020-10-29 Regeneron Pharma Humanized m-csf mice
SMT201900478T1 (it) 2011-10-28 2019-09-09 Regeneron Pharma Topi con complesso maggiore di istocompatibilita' geneticamente modificati
SMT202200205T1 (it) 2011-10-28 2022-07-21 Regeneron Pharma Topi geneticamente modificati che esprimono molecole chimeriche del complesso maggiore di istocompatibilità (mhc) ii
CN108866101A (zh) * 2011-10-28 2018-11-23 瑞泽恩制药公司 人源化il-6和il-6受体
US8962913B2 (en) 2012-06-18 2015-02-24 Regeneron Pharmaceuticals, Inc. Humanized IL-7 rodents
US9574004B2 (en) * 2012-08-21 2017-02-21 Sanofi Biotechnology Methods for treating or preventing asthma by administering an IL-4R antagonist
FI2892330T3 (fi) 2012-09-07 2023-03-25 Univ Yale Geneettisesti muokattuja hiiriä ja menetelmiä niiden käyttämiseksi
MX377561B (es) 2012-11-05 2025-03-10 Regeneron Pharma Animales no humanos genéticamente modificados y métodos de uso de los mismos.
CN111484999B (zh) 2013-02-20 2024-10-25 瑞泽恩制药公司 人源化的t细胞共受体的小鼠
EP3699190B9 (en) 2013-02-22 2023-10-04 Regeneron Pharmaceuticals, Inc. Murine cell expressing humanized major histocompatibility complex
JO3532B1 (ar) 2013-03-13 2020-07-05 Regeneron Pharma الأجسام المضادة لمضاد انترلوكين-33 واستعمالاتها
TR201901782T4 (tr) 2013-09-23 2019-03-21 Regeneron Pharma İnsanlaştirilmiş bi̇r si̇nyal düzenleyi̇ci̇ protei̇n geni̇ne sahi̇p olan i̇nsan dişi hayvanlar.
ES2613379T3 (es) 2013-10-15 2017-05-24 Regeneron Pharmaceuticals, Inc. Animales con IL-15 humanizada
CA2929846C (en) 2013-11-19 2020-09-15 Regeneron Pharmaceuticals, Inc. Non-human animals having a humanized b-cell activating factor gene
RU2671101C1 (ru) 2013-11-19 2018-10-29 Регенерон Фармасьютикалс, Инк. Отличные от человека животные, содержащие гуманизированный ген индуцирующего пролиферацию лиганда
CN111690052B (zh) 2014-04-08 2024-06-04 瑞泽恩制药公司 具有人源化FC-γ受体的非人动物
EP3636073B1 (en) 2014-05-05 2023-11-15 Regeneron Pharmaceuticals, Inc. Humanized c5 and c3 animals
NO2785538T3 (enExample) 2014-05-07 2018-08-04

Similar Documents

Publication Publication Date Title
JP2017514501A5 (enExample)
JP7755699B2 (ja) ヒト化ＩＬ－４およびＩＬ－４Ｒα動物
He et al. Hepatitis D virus infection of mice expressing human sodium taurocholate co-transporting polypeptide
US10655144B2 (en) Nucleic acid construct with a p16 promoter that causes a prodrug converting enzyme to be expressed specifically in senescent cells
JP2019047818A5 (enExample)
JP6636486B2 (ja) ヒト化ジペプチジルペプチダーゼｉｖ（ｄｐｐ４）動物
JP2018500896A5 (enExample)
JP2011501652A5 (enExample)
HRP20251062T1 (hr) Neljudske životinje koje imaju gen humaniziranog proteina za reguliranje signala
JP2017213006A5 (enExample)
JP2019511918A5 (enExample)
JP2019506897A5 (enExample)
JP2019505216A5 (enExample)
JP2010514421A5 (enExample)
CN118581158A (zh) 一种限制型心肌病动物模型的构建方法
JP2022517101A5 (enExample)
US20220192165A1 (en) Non-human animals having a humanized tslp gene, a humanized tslp receptor gene, and/or a humanized il7ra gene
Araya et al. Interferon signaling modulates Down syndrome-associated Alzheimer’s disease pathology in a mouse model
RU2788523C2 (ru) ЖИВОТНЫЕ С ГУМАНИЗИРОВАННЫМИ IL-4 И IL-4Rα
RU2020135272A (ru) Модели заболевания ditra на животных, отличных от человека, и пути их применения
CN110564771A (zh) 脑钙化病模型的制备方法
JP2005087164A (ja) ノックアウトマウス